In contrast to AA, GA has been shown to form stable adducts with DNA in mice and rats after AA treatment and mice seem According to a multiplicative model for prediction of cancer to have higher GA adduct levels than rats (5). Experimental risk for genotoxic agents the incremental cancer risk is, data show that, with respect to tumor induction, mice are more for low-intermediate exposures, proportional to target sensitive to AA than rats (1, 6 ). doses of the genotoxic substance and to the background A multiplicative model, linear at low-intermediate doses, risk in control groups. This model has been applied to has been proposed for prediction of cancer risk for genotoxic evaluate cancer tests of acrylamide in rodents. Because of chemicals (7). This model is already in use for cancer risk its reactivity toward DNA, glycidamide is assumed to be the projection of exposure to ionizing radiation. According to this causative genotoxic metabolite of acrylamide. Evaluation of model the incremental cancer morbidity or mortality, denoted experimental data according to the multiplicative model ∆P, is proportional both to the dose (D) and to P 0 , i.e. the shows that mice, compared with rats, are of the order of total or site-specific background cancer risk, 10 times more sensitive per administered dose of acrylamide. The US EPA procedure would, however, generally ∆P ϭ β·D·P 0 predict rats to be about twice as sensitive as mice to carcinogenic chemicals, because their estimates are based Dose means the accumulated lifetime dose of the genotoxic factor in the target organs. The risk coefficient β is approxion scaling of the dose per square meter body surface area, as a surrogate for metabolic differences between the species. mately the same for different sites and, as has been shown for radiation, presumably also for different species (7). For The comparison of rats and mice with respect to observed cancer incidence is at a key position in the evaluation of γ-radiation and X-rays β is~0.4% of P 0 per rad for mice, dogs and humans. In consequence, the total tumor incidence at the usefulness of risk models for extrapolation between species. In the present study mice and rats were compared, responding sites gives a safer measure of the risk than data for individual cancer types and, furthermore, the model with respect to in vivo doses of acrylamide and the metabolite glycidamide, after exposure to acrylamide. The relative facilitates interspecies extrapolation if properly defined doses are used. in vivo doses were inferred from levels of hemoglobin adducts. The adduct levels from glycidamide were, per
In contrast to a multiplicative model, most models used are additive, i.e. the risk increment, which is proportional to dose, administered dose of acrylamide,~3-10 times higher in mice than in rats. In combination with the above mentioned is independent of and added to the background risk, P 0 . For published cancer test data this model has been evaluated higher sensitivity of mice than rats in cancer tests of acrylamide this is compatible with the concept that glycidafor several chemicals, including AA (7). For chemicals, however, a dose can be defined at different levels: exposure dose, mide is the key genotoxic factor in acrylamide exposure. Furthermore, it is shown that the multiplicative, i.e. relative, absorbed dose, in vivo dose and target dose (8). Absorbed dose is given in mg or mmol per kg body wt and if multiplied risk model and measurements of the dose of the genotoxic factor give good prediction of the observed risk from by the in vivo lifespan of the chemical or of a formed reactive metabolite the in vivo dose is obtained. The in vivo dose is acrylamide in cancer tests with rats and mice.
defined as the time integral of concentration ('area under the curve'), which is comparable with radiation doses expressed as energy absorbed per unit mass. The dose in the blood is often used as the in vivo dose, expressed as levels of adducts Acrylamide (AA) is a reactive vinyl monomer used in the synthesis of polyacrylamide products, inter alia as a flocculent for waste water treatment, as a grouting agent, as a soil stabilizer, as an additive in paper and textiles, etc. AA can be absorbed into the body through the skin, by inhalation and via the gastrointestinal tract. AA is neurotoxic, with effects on both the central and peripheral nervous systems, is a skin and animals were treated with AA (acrylamide for electrophoresis; (GC-MS/MS). The AA adduct levels were quantified and the levels of GA adducts were estimated relative to the AA adduct levels by comparing the respective peak areas in the GC-MS/ MS chromatograms. The results show differences in adduct levels in the two and mice, compared with relative sensitivity/cancer risk inferred from the species. The AA adduct level per administered amount of AA calculated DD values in Table I was~3 times higher in rats than in mice. The relative adduct levels of GA per administered amount of AA was 3-10 times
Relative GA dose Relative sensitivity/cancer risk per absorbed amount of AA per absorbed amount of AA higher in mice than in rats (Table II) . These differences are evidently consequences of the metabolism of AA to GA being a Values for rat set ϭ 1. b In the cancer tests the rats were exposed for 2 years whereas mice received After per os administration of AA (and acrylonitrile) rats had the dose for a restricted time at a younger age (Table I) . As shown for higher levels of GSH-conjugated AA in the urine compared radiation, animals are more sensitive to exposure at a younger age compared with mice, while the levels of free and GSH-conjugated GA with lifelong treatment. For radiation exposure a factor of~2~3 was were higher in mice than in rats.
obtained in an evaluation of an experimental study with mice (7), in agreement with data for humans (14) . If the same is valid for chemical Reactivity of the N-terminal valine in hemoglobin is expected mutagens it would lead to a reduction in the ratio of DD values for mice in to be approximately the same for rat and mouse globins (7); Table II from 10-20 to~3-10. therefore, the ratio of adduct levels in these proteins will reflect the ratio of in vivo doses. Thus the relative in vivo dose of GA, per administered dose of AA, was found to be~3-10 to blood proteins or to DNA in leukocytes. The dose in the target organs, the target dose, may in many cases be estimated times higher in mice than in rats. Strictly speaking this factor refers to doses in blood. Considering the rapid distribution from the dose in the blood.
For extrapolation between species the multiplicative model (10) and relatively long lifespans (2) of AA and GA in the body the same factor is with some certainty approximately has to be based on the in vivo dose. However, for evaluation of the applicability of the model to published cancer tests the valid for target doses as well. Table II shows the relative GA doses and the relative administered/absorbed dose, if proportional to the in vivo dose, could be used. The sensitivity may then be expressed as the sensitivity to cancer (cancer risk) evaluated according to the multiplicative model for mice and rats after exposure to AA. inverse of the doubling dose (DD), e.g. the dose that leads to risk increments as great as P 0 .
Comparison of the data shows agreement between the relative in vivo GA dose levels per administered dose of AA and the The evaluation of published cancer test data on AA showed that the lifetime absorbed DD for mice was 20-50 mg/kg body experimentally found relative cancer risk.
The present results are in agreement with GA being the wt and for rats~500 mg/kg body wt (Table I) . This means that, with respect to tumor induction, mice are 10-20 times genotoxic agent in exposure to AA. The finding that the interspecies ratio of sensitivities is compatible with the ratio of more sensitive compared with rats per unit absorbed lifetime dose of AA (Table II) . As shown in the footnote to Table II, GA doses gives, furthermore, support to the coefficient β in the risk model (see above) being approximately the same in it is possible that this sensitivity ratio of 10-20 should be reduced to 3-10, considering the effect of age at exposure. different species, as indicated for ionizing radiation (7). It also supports the applicability of the multiplicative model for cancer If the multiplicative model is valid for interspecies extrapolation the relative sensitivity should be proportional to the risk assessment. This model is based on the lifetime dose of the (predominant) genotoxic compound or metabolite and the relative in vivo dose of the genotoxic factor. In the present study mice and rats were compared, with respect to in vivo relative increment (above the background, P 0 ) in the total incidence of tumors at responsive sites. doses of AA and the putatively genotoxic metabolite GA, after exposure to AA. The relative in vivo doses were obtained from
In a published quantitative cancer risk assessment of AA by the US EPA (11) extrapolation from rats to humans was levels of hemoglobin adducts.
Male mice (strain CBA; B&K Universal, Sollentuna, performed using a linear model for risk assessment, with a trans-species conversion based on scaling of the dose per Sweden) and male rats (Sprague-Dawley; Charles River Sverige AB, Uppsala, Sweden), 7-8 weeks old, were used. The square meter body surface area, as a default surrogate for
